ERAS
ERASCA (ERAS)
NASDAQ
$17.28+$1.80 (+11.63%)
Price as of Nov 11, 2026 7:35 PM EST
  • $5.4B
    Market Cap
  • 555.93%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

N/A
Valuation
ERAS
vs History
vs S&P 500
Profitability
-1
Growth
-0
Low Earnings Volatility
0

Momentum Score

Score: 89
Valuation
ERAS
vs History
vs S&P 500
3-Month Momentum
-14.68%
12-Month Momentum
575.11%
3-Month Risk Adjusted Momentum
-60.36%
12-Month Risk Adjusted Momentum
574.64%

True Yield

N/A
Valuation
ERAS
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
N/A

Financial Health Score

N/A
Valuation
ERAS
vs History
vs S&P 500
Ohlson's O-Score
-1